| Bioactivity | Linezolid (PNU-100766) is the first member of the class of oxazolidinone synthetic antibiotic. Linezolid acts by inhibiting the initiation of bacterial protein synthesis. Linezolid is used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics[1][2][3]. |
| Invitro | Linezolid (PNU-100766) prevents the synthesis of bacterial protein via binding to rRNA on both the 30S and 50S ribosomal subunits[3]. |
| Name | Linezolid |
| CAS | 165800-03-3 |
| Formula | C16H20FN3O4 |
| Molar Mass | 337.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
Linezolid
CAS: 165800-03-3 F: C16H20FN3O4 W: 337.35
Linezolid (PNU-100766) is the first member of the class of oxazolidinone synthetic antibiotic. Linezolid acts by inhibit
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.